S. Hegewisch-Becker
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Surgery
- Pathology and Forensic Medicine top 10%
- Co-authors
- Ullrich GraevenWolff SchmiegelDirk ArnoldDieter K. HossfeldHans‐Joachim SchmollAndrea TannapfelNicolaus KrögerEwald Wöll
- Topics
- Colorectal Cancer Treatments and Studies (12 papers)Gastric Cancer Management and Outcomes (9 papers)Cancer Treatment and Pharmacology (6 papers)
- Cited by
- OncologyHematologyHepatology
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
S. Hegewisch-Becker
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Oncology 665
- Pulmonary and Respiratory Medicine 395
- Molecular Biology 215
- Surgery 170
- Pathology and Forensic Medicine 167
Countries citing papers authored by S. Hegewisch-Becker
This map shows the geographic impact of S. Hegewisch-Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hegewisch-Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hegewisch-Becker more than expected).
Fields of papers citing papers by S. Hegewisch-Becker
This network shows the impact of papers produced by S. Hegewisch-Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hegewisch-Becker. The network helps show where S. Hegewisch-Becker may publish in the future.
Co-authorship network of co-authors of S. Hegewisch-Becker
This figure shows the co-authorship network connecting the top 25 collaborators of S. Hegewisch-Becker. A scholar is included among the top collaborators of S. Hegewisch-Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Hegewisch-Becker. S. Hegewisch-Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 59 | |
| 3 | 213 | |
| 4 | 20 | |
| 5 | 8 | |
| 6 | 141 | |
| 7 | 9 | |
| 8 | 100 | |
| 9 | 36 | |
| 10 | 43 | |
| 11 | 23 | |
| 12 | 19 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 62 | |
| 16 | 21 | |
| 17 | 22 | |
| 18 | Expression of multidrug resistance (mdr-1) and p53 genes in hematologic cell systems: Implications for biology and gene therapy | 4 |
| 19 | 4 | |
| 20 | 21 |
About S. Hegewisch-Becker
S. Hegewisch-Becker is a scholar working on Oncology, Hepatology and Hematology, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (9 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Oncology (665 citations), Hematology (156 citations) and Hepatology (109 citations). S. Hegewisch-Becker has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Ullrich Graeven, Wolff Schmiegel, Dirk Arnold, Dieter K. Hossfeld, Hans‐Joachim Schmoll, Andrea Tannapfel, Nicolaus Kröger, Ewald Wöll, Falko Fend and Gunnar Folprecht. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.